General form of registration statement for all companies including face-amount certificate companies

SEGMENT REPORTING (Tables)

v3.21.2
SEGMENT REPORTING (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Segment Reporting [Abstract]    
Schedule of segment reporting information, by segment
 

Six Months Ended

 

Three Months Ended

   

June 30,
2021

 

June 30,
2020

 

June 30,
2021

 

June 30,
2020

Segment Net Sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cannabinoid

 

$

1,256

 

 

$

395

 

 

$

579

 

 

$

153

 

Non-Cannabinoid

 

 

5,893

 

 

 

4,458

 

 

 

3,093

 

 

 

1,786

 

Total Net Sales

 

 

7,149

 

 

 

4,853

 

 

 

3,672

 

 

 

1,939

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment Profit (Loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cannabinoid

 

 

(6,468

)

 

 

(9,855

)

 

 

(3,604

)

 

 

(4,454

)

Non-Cannabinoid

 

 

1,246

 

 

 

413

 

 

 

634

 

 

 

(67

)

Total Segment Loss

 

$

(5,222

)

 

$

(9,442

)

 

$

(2,970

)

 

$

(4,521

)

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Segment Loss

 

 

(5,222

)

 

 

(9,442

)

 

 

(2,970

)

 

 

(4,521

)

Unallocated corporate expenses

 

 

(6,173

)

 

 

(3,945

)

 

 

(2,786

)

 

 

(2,141

)

Non-cash share based compensation

 

 

(4,873

)

 

 

(713

)

 

 

(3,323

)

 

 

(297

)

Depreciation and amortization

 

 

(1,103

)

 

 

(717

)

 

 

(524

)

 

 

(365

)

Goodwill impairment

 

 

 

 

 

(1,682

)

 

 

 

 

 

 

Loss from operations

 

$

(17,371

)

 

$

(16,499

)

 

$

(9,603

)

 

$

(7,325

)

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on fair value of derivative instrument

 

 

 

 

 

 

 

 

 

 

 

(13

)

Loss(gain) on remeasurement of warrant liability

 

 

3,675

 

 

 

 

 

 

(1,176

)

 

 

 

Loss on investments

 

 

 

 

 

228

 

 

 

 

 

 

67

 

Foreign exchange loss

 

 

839

 

 

 

359

 

 

 

80

 

 

 

311

 

Interest expense

 

 

1,898

 

 

 

1,789

 

 

 

920

 

 

 

953

 

Miscellaneous, net

 

 

(1,087

)

 

 

48

 

 

 

(485

)

 

 

105

 

Loss before loss from equity investment

 

$

(22,696

)

 

$

(18,923

)

 

$

(8,942

)

 

$

(8,748

)

 

June 30,
2021

 

December 31, 2020

Long-lived assets

 

 

   

 

 

Cannabinoid

 

$

28,528

 

$

25,485

Non-Cannabinoid

 

 

151

 

 

176

Other(a)

 

 

25

 

 

19

   

$

28,704

 

$

25,680

 

Year ended

   

December 31, 2020
(Restated)(a)

 

December 31, 2019

Segment Net Sales:

 

 

 

 

 

 

 

 

Cannabinoid

 

$

2,511

 

 

$

133

 

Non-Cannabinoid

 

 

9,606

 

 

 

7,701

 

Total Net Sales

 

 

12,117

 

 

 

7,834

 

   

 

 

 

 

 

 

 

Segment Profit (Loss):

 

 

 

 

 

 

 

 

Cannabinoid

 

 

(18,798

)

 

 

(25,250

)

Non-Cannabinoid

 

 

1,863

 

 

 

614

 

Total Loss

 

$

(16,935

)

 

$

(24,636

)

   

 

 

 

 

 

 

 

Reconciliation:

 

 

 

 

 

 

 

 

Total Segment Loss

 

 

(16,935

)

 

 

(24,636

)

Unallocated corporate expenses

 

 

(6,405

)

 

 

(5,887

)

Non-cash share based compensation

 

 

(1,652

)

 

 

(1,522

)

Depreciation and amortization

 

 

(1,854

)

 

 

(1,480

)

Herbal Brands acquisition related charges

 

 

 

 

 

(3,015

)

Goodwill impairment

 

 

(1,682

)

 

 

 

Loss from operations

 

$

(28,528

)

 

$

(36,540

)

   

 

 

 

 

 

 

 

Loss on debt extinguishment

 

 

2,360

 

 

 

3,374

 

Gain on remeasurement of warrant liability

 

 

(10,780

)

 

 

 

Loss on fair value of derivative instrument

 

 

657

 

 

 

421

 

Loss on investments

 

 

464

 

 

 

756

 

Foreign exchange loss

 

 

491

 

 

 

1,575

 

Interest expense

 

 

4,455

 

 

 

2,684

 

Miscellaneous, net

 

 

(284

)

 

 

534

 

Loss from operations before income taxes

 

$

(25,891

)

 

$

(45,884

)

 

December 31, 2020

 

December 31, 2019

Long-lived assets

 

 

   

 

 

Cannabinoid

 

$

25,485

 

$

24,209

Non-Cannabinoid

 

 

176

 

 

207

Other(a)

 

 

19

 

 

16

   

$

25,680

 

$

24,432

(a)      “Other” includes long-lived assets primarily in the Company’s corporate offices.

Schedule of disaggregation of revenue by channel
 

Six Months Ended

 

Three Months Ended

   

June 30,
2021

 

June 30,
2020

 

June 30,
2021

 

June 30,
2020

Mass retail

 

$

3,609

 

$

2,033

 

$

1,721

 

$

1,012

Specialty, health and other retail

 

 

575

 

 

910

 

 

350

 

 

598

Distributors

 

 

2,680

 

 

1,575

 

 

1,448

 

 

236

E-commerce

 

 

285

 

 

335

 

 

153

 

 

93

   

$

7,149

 

$

4,853

 

$

3,672

 

$

1,939

 

Year ended

   

December 31, 2020

 

December 31, 2019

Mass retail

 

$

6,879

 

$

3,318

Specialty, health and other retail

 

 

689

 

 

1,235

Distributors

 

 

4,036

 

 

2,397

E-commerce

 

 

513

 

 

885

   

$

12,117

 

$

7,834